Laverock Therapeutics has announced new in vivo programmes spanning CAR‑T and genetic medicine, expanding its therapeutic ...
Atrogi has announced positive human data for ATR‑258, its first‑in‑class oral GRK2‑biased β2‑adrenergic modulator designed to improve muscle function and body composition. In an 8‑week ...
Mums whose babies developed life‑threatening sepsis and meningitis from group B streptococcus are urging pregnant women to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results